Yu‐Sheng Chao

4.7k citations
98 papers · 3.7k indexed · h-index 36

Yu‐Sheng Chao

98 papers receiving 3.6k citations

Peers

Yu‐Sheng Chao
Comparison fields: 5 of 126
  • Biochemistry 205
  • Endocrinology, Diabetes and Metabolism 452
  • Cancer Research 357
  • Molecular Biology 1.6k
  • Computational Theory and Mathematics 354
Replace Guang Liang with:
Guang Liang China
Changyuan Wang China
SubbaRao V. Madhunapantula India
Hany A. Omar United Arab Emirates
Chunlin Zhuang China
Ramiro Jover Spain
Johannes M. Breuss Austria
Yong Zhou China
Anas Shamsi India
Shu-Feng Zhou China
Yu‐Sheng Chao relative to Guang Liang China Guang Liang's profile →
Citations per field
00.5×2.8×
Guang Liang · 1×
Citations per year

Countries citing papers authored by Yu‐Sheng Chao

Since Specialization
Citations

This map shows the geographic impact of Yu‐Sheng Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Sheng Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Sheng Chao more than expected).

Fields of papers citing papers by Yu‐Sheng Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Sheng Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Sheng Chao. The network helps show where Yu‐Sheng Chao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yu‐Sheng Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu‐Sheng Chao Line = papers co-authored together Yu‐Sheng Chao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20225
2 201713
3 201419
4 201212
5 201114
6 201111
7 201010
8 201023
9 201015
10 20097
11 200948
12 20099
13 200810
14 20088
15
Anti-influenza drug discovery
20071
16 200426
17 20028
18 2002165
19 200153
20 2000177

About Yu‐Sheng Chao

Yu‐Sheng Chao is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Hepatology, having authored 98 papers that have together received 3.7k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (18 papers), Diabetes Treatment and Management (15 papers), Neuropeptides and Animal Physiology (10 papers), Peptidase Inhibition and Analysis (10 papers), Hepatitis C virus research (8 papers), Cholesterol and Lipid Metabolism (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Biochemistry (205 citations), Endocrinology, Diabetes and Metabolism (452 citations) and Cancer Research (357 citations). Yu‐Sheng Chao has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Samuel D. Wright, Melba Hernandez, Charlotte Burton, Patricia A. Detmers, Carl P. Sparrow, Steven S. Mundt, Anne Hermanowski‐Vosatka, Teng‐Kuang Yeh, Shiow‐Ju Lee and Sushma Patel. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026